NasdaqGS:IDXXMedical Equipment
IDEXX Laboratories (IDXX) Could Be 22% Undervalued As New Cardiac Test Expands Its Reach
New cardiac test launch puts IDEXX Laboratories stock in focus
IDEXX Laboratories (IDXX) has drawn fresh investor attention after announcing the Catalyst proBNP Test, a dual species in-clinic NT proBNP assay that extends its cardiac diagnostics offering for companion animals.
See our latest analysis for IDEXX Laboratories.
The cardiac test launch arrives during a weaker patch for IDEXX Laboratories’ share price, with the stock down 17.41% year to date on a share price basis and total...